FDA Warns of Excess Mortality to Elderly With Antipsychotics
WASHINGTON-The FDA has issued a public health advisory on the entire class of atypical antipsychotic drugs, pointing to an apparent excess of mortality for older patients with dementia, particularly when the agents are used off-label to treat behavioral disorders.
Apr 12, 2005